Literature DB >> 9883073

Diagnostic electrocardiography in epidemiological studies of Chagas' disease: multicenter evaluation of a standardized method.

J O Lázzari1, M Pereira, C M Antunes, A Guimarães, A Moncayo, R Chávez Domínguez, O Hernández Pieretti, V Macedo, A Rassi, J Maguire, A Romero.   

Abstract

An electrocardiographic recording method with an associated reading guide, designed for epidemiological studies on Chagas' disease, was tested to assess its diagnostic reproducibility. Six cardiologists from five countries each read 100 electrocardiographic (ECG) tracings, including 30 from chronic chagasic patients, then reread them after an interval of 6 months. The readings were blind, with the tracings numbered randomly for the first reading and renumbered randomly for the second reading. The physicians, all experienced in interpreting ECGs from chagasic patients, followed printed instructions for reading the tracings. Reproducibility of the readings was evaluated using the kappa (kappa) index for concordance. The results showed a high degree of interobserver concordance with respect to the diagnosis of normal vs. abnormal tracings (kappa = 0.66; SE 0.02). While the interpretations of some categories of ECG abnormalities were highly reproducible, others, especially those having a low prevalence, showed lower levels of concordance. Intraobserver concordance was uniformly higher than interobserver concordance. The findings of this study justify the use by specialists of the recording of readings method proposed for epidemiological studies on Chagas' disease, but warrant caution in the interpretation of some categories of electrocardiographic alterations.

Entities:  

Mesh:

Year:  1998        PMID: 9883073     DOI: 10.1590/s1020-49891998001100005

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  6 in total

1.  Electrocardiographic and echocardiographic abnormalities in Chagas disease: findings in residents of rural Bolivian communities hyperendemic for Chagas disease.

Authors:  Antonio B Fernandez; Maria Carmo P Nunes; Eva H Clark; Aaron Samuels; Silvio Menacho; Jesus Gomez; Ricardo W Bozo Gutierrez; Thomas C Crawford; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

2.  A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (the Bambuí Study).

Authors:  M Fernanda Lima-Costa; Erico Castro-Costa; Elizabeth Uchôa; Joselia Firmo; Antonio Luiz P Ribeiro; Cleusa P Ferri; Martin Prince
Journal:  Neuroepidemiology       Date:  2008-12-16       Impact factor: 3.282

3.  Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.

Authors:  Jessica E Yager; Daniel F Lozano Beltran; Faustino Torrico; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

4.  Sustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in Bolivia.

Authors:  Michelle Kaplinski; Malasa Jois; Gerson Galdos-Cardenas; Victoria R Rendell; Vishal Shah; Rose Q Do; Rachel Marcus; Melissa S Burroughs Pena; Maria del Carmen Abastoflor; Carlos LaFuente; Ricardo Bozo; Edward Valencia; Manuela Verastegui; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

5.  Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study.

Authors:  Lisandro D Colantonio; Nilda Prado; Elsa L Segura; Sergio Sosa-Estani
Journal:  PLoS Negl Trop Dis       Date:  2016-05-09

6.  Improved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural Bolivia.

Authors:  Jeffrey A Tornheim; Daniel F Lozano Beltran; Robert H Gilman; Mario Castellon; Marco A Solano Mercado; Walter Sullca; Faustino Torrico; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.